Free Trial
→ Why this tiny stock may move before the SpaceX IPO drops (From Behind the Markets) (Ad)tc pixel Free UPHL Stock Alerts

UpHealth (UPHL) Competitors

$0.0003 0.00 (0.00%)
As of 06/16/2026 11:42 AM Eastern
Compare

UPHL vs. BTTX, ACONW, AONC, DHACW, and LFMDP

Should you buy UpHealth stock or one of its competitors? MarketBeat compares UpHealth with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with UpHealth include Better Therapeutics (BTTX), Aclarion (ACONW), American Oncology Network (AONC), Digital Health Acquisition (DHACW), and LifeMD (LFMDP). These companies are all part of the "healthcare" industry.

How does UpHealth compare to Better Therapeutics?

Better Therapeutics (NASDAQ:BTTX) and UpHealth (NYSE:UPHL) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, profitability, institutional ownership, earnings, valuation, media sentiment, dividends and analyst recommendations.

34.0% of Better Therapeutics shares are held by institutional investors. Comparatively, 56.1% of UpHealth shares are held by institutional investors. 51.4% of Better Therapeutics shares are held by insiders. Comparatively, 34.2% of UpHealth shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Better Therapeutics has higher earnings, but lower revenue than UpHealth. Better Therapeutics is trading at a lower price-to-earnings ratio than UpHealth, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Better TherapeuticsN/AN/A-$39.76M-$0.78N/A
UpHealth$130M0.00-$56.42M$1.470.00

Company Net Margins Return on Equity Return on Assets
Better TherapeuticsN/A N/A N/A
UpHealth N/A N/A N/A

Better Therapeutics has a beta of 0.88, meaning that its share price is 12% less volatile than the broader market. Comparatively, UpHealth has a beta of 0.5, meaning that its share price is 50% less volatile than the broader market.

In the previous week, Better Therapeutics' average media sentiment score of 0.00 equaled UpHealth'saverage media sentiment score.

Company Overall Sentiment
Better Therapeutics Neutral
UpHealth Neutral

Summary

Better Therapeutics beats UpHealth on 4 of the 7 factors compared between the two stocks.

How does UpHealth compare to Aclarion?

UpHealth (NYSE:UPHL) and Aclarion (NASDAQ:ACONW) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, analyst recommendations, valuation, profitability, earnings, dividends and risk.

Company Net Margins Return on Equity Return on Assets
UpHealthN/A N/A N/A
Aclarion N/A N/A N/A

In the previous week, Aclarion's average media sentiment score of 0.44 beat UpHealth's score of 0.00 indicating that Aclarion is being referred to more favorably in the news media.

Company Overall Sentiment
UpHealth Neutral
Aclarion Neutral

Aclarion has lower revenue, but higher earnings than UpHealth.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
UpHealth$130M0.00-$56.42M$1.470.00
Aclarion$77.88KN/AN/AN/AN/A

56.1% of UpHealth shares are owned by institutional investors. 34.2% of UpHealth shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

UpHealth beats Aclarion on 3 of the 4 factors compared between the two stocks.

How does UpHealth compare to American Oncology Network?

UpHealth (NYSE:UPHL) and American Oncology Network (OTCMKTS:AONC) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, media sentiment, earnings, risk and valuation.

American Oncology Network has higher revenue and earnings than UpHealth.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
UpHealth$130M0.00-$56.42M$1.470.00
American Oncology Network$1.34BN/AN/AN/AN/A

In the previous week, American Oncology Network had 3 more articles in the media than UpHealth. MarketBeat recorded 3 mentions for American Oncology Network and 0 mentions for UpHealth. American Oncology Network's average media sentiment score of 0.23 beat UpHealth's score of 0.00 indicating that American Oncology Network is being referred to more favorably in the news media.

Company Overall Sentiment
UpHealth Neutral
American Oncology Network Neutral

56.1% of UpHealth shares are held by institutional investors. 34.2% of UpHealth shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Company Net Margins Return on Equity Return on Assets
UpHealthN/A N/A N/A
American Oncology Network N/A N/A N/A

Summary

American Oncology Network beats UpHealth on 3 of the 5 factors compared between the two stocks.

How does UpHealth compare to Digital Health Acquisition?

Digital Health Acquisition (NASDAQ:DHACW) and UpHealth (NYSE:UPHL) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, earnings, media sentiment, profitability, institutional ownership and dividends.

Digital Health Acquisition has higher earnings, but lower revenue than UpHealth.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Digital Health AcquisitionN/AN/AN/AN/AN/A
UpHealth$130M0.00-$56.42M$1.470.00

In the previous week, Digital Health Acquisition's average media sentiment score of 0.00 equaled UpHealth'saverage media sentiment score.

Company Overall Sentiment
Digital Health Acquisition Neutral
UpHealth Neutral

56.1% of UpHealth shares are held by institutional investors. 34.2% of UpHealth shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Company Net Margins Return on Equity Return on Assets
Digital Health AcquisitionN/A N/A N/A
UpHealth N/A N/A N/A

Summary

UpHealth beats Digital Health Acquisition on 3 of the 3 factors compared between the two stocks.

How does UpHealth compare to LifeMD?

UpHealth (NYSE:UPHL) and LifeMD (NASDAQ:LFMDP) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, valuation, earnings, profitability, analyst recommendations, dividends, institutional ownership and media sentiment.

56.1% of UpHealth shares are owned by institutional investors. 34.2% of UpHealth shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Company Net Margins Return on Equity Return on Assets
UpHealthN/A N/A N/A
LifeMD N/A N/A N/A

LifeMD has higher revenue and earnings than UpHealth.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
UpHealth$130M0.00-$56.42M$1.470.00
LifeMD$193.33MN/AN/AN/AN/A

In the previous week, LifeMD had 1 more articles in the media than UpHealth. MarketBeat recorded 1 mentions for LifeMD and 0 mentions for UpHealth. LifeMD's average media sentiment score of 0.29 beat UpHealth's score of 0.00 indicating that LifeMD is being referred to more favorably in the news media.

Company Overall Sentiment
UpHealth Neutral
LifeMD Neutral

Summary

LifeMD beats UpHealth on 3 of the 5 factors compared between the two stocks.

Get UpHealth News Delivered to You Automatically

Sign up to receive the latest news and ratings for UPHL and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding UPHL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

UPHL vs. The Competition

Export
MetricUpHealthHealth services IndustryMedical SectorNYSE Exchange
Market Cap$6K$1.23M$6.49B$23.37B
Dividend YieldN/AN/A2.67%4.06%
P/E Ratio0.00N/A23.8831.33
Price / Sales0.000.00520.1320.52
Price / CashN/AN/A44.1324.42
Price / Book0.000.0010.574.68
Net Income-$56.42M-$56.42M$3.56B$1.07B
7 Day PerformanceN/AN/A0.89%1.82%
1 Month PerformanceN/AN/A1.54%3.19%
1 Year PerformanceN/AN/A26.49%23.54%

UpHealth Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
UPHL
UpHealth
N/A$0.00
flat		N/A+50.0%$6K$130MN/A1,750
BTTX
Better Therapeutics
N/A$0.00
flat		N/AN/A$4KN/AN/A40
ACONW
Aclarion
N/A$0.03
+7.6%		N/A-25.2%$0.00$77.88KN/A7
AONC
American Oncology Network
N/A$12.00
flat		N/AN/A$0.00$1.34BN/A1,520
DHACW
Digital Health Acquisition
N/A$0.04
flat		N/A-11.8%$0.00N/AN/AN/A

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NYSE:UPHL) was last updated on 6/17/2026 by MarketBeat.com Staff.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Is SpaceX really worth 1.78 Trillion?
With SpaceX approaching a near-$2 trillion valuation, most investors are focused on the IPO itself - but analy...
InvestPub | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
The roadshow starts Monday. This stock isn't ready.
The SpaceX roadshow kicks off June 8. Goldman Sachs, the lead underwriter, will present the full S-1 to the wo...
Behind the Markets | Sponsoredtc pixel
SpaceX is chump change compared to Elon’s $20T ‘iPhone’
Early Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...
StocksToTrade | Sponsoredtc pixel
Trump just signed it
A recent policy development is drawing attention from income-focused investors. According to one analyst, c...
Investors Alley | Sponsoredtc pixel
This is the worst news for stocks in 50 years
Goldman Sachs and Morgan Stanley are issuing a rare warning: what's ahead for U.S. stocks could be the worst e...
TradeSmith | Sponsoredtc pixel